ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,184
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
A phase I study of toripalimab, an anti-PD-1 antibody, in patients with refractory malignant solid tumors
Author(s):
X.L. Wei
,
C. REN
,
F.H. Wang
Publication date:
2020
Journal:
Cancer Commun
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Anti-Trafficking Review
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
2,184
A phase Ib/II clinical trial of tolerability, safety and efficacy of regorafenib in combination with toripalimab (a PD-1 antibody) in patients with relapsed or metastatic colorectal cancer, 2020
Authors:
FHM Wang
,
Y Yao
,
Z. WANG
…
P-170 Exploratory biomarker findings from regorafenib plus toripalimab in patients with refractory metastatic colorectal cancer (REGOTORI study)
Authors:
Y Yao
,
Y Jin
,
M WANG
Real-world outcomes of toripalimab (JS001) in advanced non-small cell lung cancer: a multicenter retrospective study
Authors:
Z Ruan
,
B. Zhu
,
N WANG
See all similar
Cited by
1
Efficacy and safety of sintilimab plus bevacizumab in metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy: an open-label phase 2 study
Authors:
Nian Lu
,
Yao-Fei Jiang
,
Wei-Xiong Xia
…
See all cited by